PMA

P170032: Woven EndoBridge (WEB) Aneurysm Embolization System

FDA PMA · Intrasaccular Flow Disruption Device · MicroVention, Inc.

Key facts

PMA number P170032
Trade name Woven EndoBridge (WEB) Aneurysm Embolization System
Generic name Intrasaccular Flow Disruption Device
Applicant MicroVention, Inc.
Owner/operator MicroVention Inc.
Product code OPR
Approval date Dec 31, 2018
Docket number 19M-0027
Notice date Jan 28, 2019
Establishment registration 3013556777
FEI number 3013556777

At a glance

  • 10–99 Supplements
  • May 28, 2026 Latest supplement decision
  • No Withdrawn
  • Yes Summary of safety and effectiveness on file
  • 10–99 UDI device identifiers (GUDID)
  • None MAUDE adverse event reports
  • None Recall events

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA approvals

Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA approvals